Within the context of this year’s German Biotech Days in Berlin the Council of German BioRegions honored researchers from Aachen, Mannheim and Magdeburg with the innovation award which is endowed with 2.000 € each.
Within the context of this year’s German Biotech Days in Berlin the Council of German BioRegions honored researchers from Aachen, Mannheim and Magdeburg with the innovation award which is endowed with 2.000 € each.
The spinoff ‘attyloid GmbH’ receives further funding for ‘sFIDA’ technology from the federate state North Rhine-Westphalia to undertake an early diagnosis on Alzheimer disease among others.
Professor Dr. Ulrich Rüdiger will return back as the principal of the RWTH Aachen on 1 August 2018 to a place where he studied, gained one’s doctorate and habilitated.
The Grünenthal Group’s subsidiary Adhesys Medical GmbH receives for its fibrin glue products Cutis the CE marking and for VIVO the EAP status.
The Ministry of economy encourages young companies with their trade fair participation at 72 international fairs. Up to trade fair participation will be supported by the government.
The general meeting 2018 of MedLife e.V. took place with a vivid contribution in the newly opened Center for Biohybrid Medical Systems (CBMS) on the RWTH Aachen Campus Melaten. Among others a new advisory board was elected.
The Institute for Nanotechnology and Biotechnology of the University of Applied Sciences celebrates its 10-year anniversary. In this regard Prof. Dr. Baumann, prinicipal of the University speaks of a ‘successful stroy’.
Since January 2018, Dr.-Ing. Laura De Laporte from the ‘DWI – Leibniz Institute für Interactive Materials’ gets encouraged for her outstanding work within the Leibniz Association’s program for female professors. The programm is part of the initiative ‘Leibniz – Best Minds’.
Gruenenthal GmbH does research on easing and preventing painful experience. 16 participants had the opportunity to do an excursion and to gain an insight in this particular field.
With this year’s Innovationspreis 2018 3 patent applications or granted applications from the field of modern biotechnology or medical engineering relating to biotechnology will be honored. The overall aim is to support scientists and researchers with their implementation of marketable ideas and their business formation.